Komori
StemCell Institute (7096) · RiskRestated

Risk of Dependence on the Representative Director

First written in FY2021. 4 of 5 entries say "Restated". Latest entry: FY2026.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20262021: 120212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Dependence on Key ExecutivesA theme 565 companies write about · 565 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 10 of 77 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 565 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The Group is securing and developing human resources and working to establish a management structure that does not depend excessively on him.」

    The risk of dependence on the Representative Director and the policy of limiting this dependence by securing and developing human resources continue to be maintained.
  2. FY2025RestatedAnnual report

    「We are securing and developing human resources and working to establish a management structure that does not depend excessively on him.」

    The risk of dependence on the Representative Director and the policy of limiting this dependence by securing and developing human resources continue to be maintained.
  3. FY2023RestatedAnnual report

    「We are securing and developing human resources and working to establish a management structure that does not depend excessively on him.」

    The risk of dependence on the Representative Director is recognized, and the policy of limiting this dependence by securing and developing human resources continues to be maintained.
  4. FY2022RestatedAnnual report

    「We are securing and developing human resources and working to establish a management structure that does not depend excessively on him.」

    The risk of dependence on the Representative Director is recognized, and the policy of limiting this dependence by securing and developing human resources continues to be maintained.
  5. FY2021First statedAnnual report

    「Shimizu Takafumi (清水 崇文), our Representative Director, has extensive knowledge, experience and a network relating to the medical business as a whole, and plays an important role in ensuring business continuity, including determining management policies and business strategies. We are securing and developing human resources and working to establish a management structure that does not depend excessively on him.」

    The policy is to limit excessive dependence on any particular individual by securing and developing human resources.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.